Clinical Trial Detail

NCT ID NCT01383148
Title Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Transgene
Indications

lung non-small cell carcinoma

Therapies

MVA-MUC1-IL2 vaccine

Age Groups: adult senior

No variant requirements are available.